Substituted hydrindanes for the treatment of angiogenesis-dependent diseases
US5686621A · kind A · utility
11Cited by
2References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 6, 1995 |
| Grant date | Nov 11, 1997 |
| Priority date | — |
| Expiry date | Jun 6, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Substituted hydrindanes and their use in controlling angiogenesis-dependent diseases in warm blooded animals are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.